Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
Adults
Clear all
Type of publications
Systematic reviews (SYSVAC)
(22)
Topics
Available to download in languages
Regions
Americas
(2)
South-East Asia
(1)
Western Pacific
(1)
Countries
Diseases
COVID-19
(1)
Human papillomavirus (HPV)
(21)
Diphtheria
(1)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(6)
HIV / AIDS
(1)
Influenza
(5)
Measles
(2)
Meningococcal disease
(1)
Mumps
(2)
Pertussis
(1)
Pneumococcal disease
(5)
Rotavirus
(1)
Rubella
(2)
Tetanus
(1)
Varicella
(2)
Vaccine topics
Economic aspects
(22)
Acceptance
(94)
Administration
(67)
Coverage
(58)
Efficacy/effectiveness
(203)
Ethical issues
(13)
Logistics
(1)
Modeling
(2)
Safety
(255)
Target population
Adults
(22)
Adolescents
(25)
All age groups
(21)
Children
(2)
Newborn
(1)
Older adults
(3)
Parents/caregivers
(1)
Publication date
2023
(2)
2022
(3)
2021
(1)
2020
(3)
2019
(2)
2018
(1)
2017
(3)
2016
(1)
2015
(2)
2014
(1)
2013
(1)
2012
(2)
22 results found
2023
∙
Segal, H. A. Rashid, N.
A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries
2023
∙
Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
2022
∙
Tran, P. T. Riaz, M. Chen, Z. Truong, C. B. Diaby, V.
An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines
2022
∙
Akumbom, A. M. Lee, J. J. Reynolds, N. R. Thayer, W. Wang, J. Slade, E.
Cost and effectiveness of HPV vaccine delivery strategies: A systematic review
2022
∙
Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
2021
∙
Morais, E. El Mouaddin, N. Schuurman, S. De, A.
Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data
2020
∙
Mahumud, R. A. Alam, K. Keramat, S. A. Ormsby, G. M. Dunn, J. Gow, J.
Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
2020
∙
Abidi, S. Labani, S. Singh, A. Asthana, S. Ajmera, P.
Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review
2020
∙
Okeah, B. O. Ridyard, C. H.
Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review
2019
∙
Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.
Cost-effectiveness of adult vaccinations: A systematic review
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register